WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells-Reference-Cited by-同舟云学术

WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells

Published:2013-04-28 Issue:5 Volume:7 Page:870-883
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Prasad Chandra Prakash,Chaurasiya Shivendra Kumar,Axelsson Lena,Andersson Tommy

Funder

Swedish Cancer Foundation

Swedish Research Council

Söderberg Foundations

Skåne University Hospital Research Foundations

Gunner Nilsson's Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2013.04.005/fullpdf

Reference69 articles.

1. Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo;Beliveau;Genes Dev.,2010

2. Wnt signaling signaling at and above the receptor level;Buechling;Curr. Top. Dev. Biol.,2011

3. Wnt signaling: a common theme in animal development;Cadigan;Genes Dev.,1997

4. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor;Chao;J. Biol. Chem.,1992

5. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression;Chen;Cancer Res.,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies;Cancers;2024-07-07

2. Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice;Cell Death Discovery;2024-02-19

3. Suspension state affects the stemness of breast cancer cells by regulating the glycogen synthase kinase-3β;Tissue and Cell;2023-12

4. β-catenin inhibitors in cancer therapeutics: intricacies and way forward;Bioengineered;2023-09

5. Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment;Cell Communication and Signaling;2023-08-03